Xiaodong M. Zhu
130 Dong' An Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 129 publications
Clinicopathological analysis of 110 cases of SMARCA4-deficient conventional non-small cell lung cancer.
Journal: Annals of diagnostic pathology
Published: July 16, 2026
A tumor cell membrane-engineered MXene nanoplatform for chemo-photothermal immunotherapy of bladder cancer.
Journal: Journal of materials chemistry. B
Published: May 01, 2026
A Phase II Clinical Trial of Chemotherapy Rechallenge with or without Targeted Therapy in Refractory Metastatic Colorectal Cancer.
Journal: Oncology research
Published: April 21, 2026
Sphincter-preserving surgery for rectal cancer--From limits to perfection
Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: January 21, 2026
A Sprayable Nanoplatform Breaks the Vicious Cycle of Diabetic Wounds via Photoactivated Antioxidant and Drug Delivery.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 19, 2025
Chinese consensus on first-line precision therapy for advanced gastric cancer.
Journal: Innovation (Cambridge (Mass.))
Published: September 16, 2025
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study.
Journal: The Lancet. Oncology
Published: April 29, 2025
Chinese expert consensus on conversion and perioperative therapy of primary liver cancer (2024 edition).
Journal: Hepatobiliary surgery and nutrition
Published: February 28, 2025
Molecular Structure Regulation Elicits Steric Hindrance of Ketone Additives with High Adsorbability for Oriented Deposition of Zn Anode.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: February 27, 2025
Improved treatment of colorectal liver metastases by early response evaluation and regimen adjustment: a prospective study of clinical functional MR-based modeling.
Journal: Cancer biology & medicine
Published: February 22, 2025
First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study.
Journal: Signal transduction and targeted therapy
Published: February 10, 2025
Last Updated: 09/26/2026